drugset / Trial / NCT07090655
A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers
RandomizedSequentialDouble-blindBasic science
Summary
The main objective is to assess the safety and tolerability of subcutaneous and intravenous injection forms of budoprutug in healthy volunteers.
Timeline
- Start
- 2025-08-11
- Primary completion
- 2026-04
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budoprutug | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.